Condensed Consolidated Statements of Operations Unaudited - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Sales	$ 1,264,638	$ 901,862
Cost of sales	771,225	880,620
Gross profit	493,413	21,242
Operating Expenses
Research and development and patents	771,180	1,292,093
General and administrative	1,421,926	1,298,731
Amortization and depreciation	54,579	54,832
Foreign Exchange (Gain) Loss	(19,310)	48,457
Total operating expenses	2,228,375	2,694,113
Other Income (Expense)
Interest and other income	57,094	136,043
Loss before income tax expense	(1,677,868)	(2,536,828)
Income tax expense
Net loss	$ (1,677,868)	$ (2,536,828)
Net loss per share
Basic (in Dollars per share)	$ (2.71)	$ (15.24)
Diluted (in Dollars per share)	$ (2.71)	$ (15.24)
Weighted average outstanding Common Shares
Basic (in Shares)	620,127	166,410
Diluted (in Shares)	620,127	166,410